Cas no 1070879-47-8 (4-Bromo-6-fluoro-2-methylquinoline)
4-Bromo-6-fluoro-2-methylquinoline Chemical and Physical Properties
Names and Identifiers
-
- 4-Bromo-6-fluoro-2-methylquinoline
- ACMC-2098nh
- AG-D-21973
- ANW-15483
- CTK4A4976
- MolPort-006-171-276
- CS-0212077
- 1070879-47-8
- DTXSID00653696
- BS-25700
- SB70125
- AKOS015835386
- MFCD11505132
-
- MDL: MFCD11505132
- Inchi: 1S/C10H7BrFN/c1-6-4-9(11)8-5-7(12)2-3-10(8)13-6/h2-5H,1H3
- InChI Key: PNUZBHRKDCGEIY-UHFFFAOYSA-N
- SMILES: BrC1C=C(C)N=C2C=CC(=CC2=1)F
Computed Properties
- Exact Mass: 238.97500
- Monoisotopic Mass: 238.97459g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 13
- Rotatable Bond Count: 0
- Complexity: 188
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 3.4
- Topological Polar Surface Area: 12.9?2
Experimental Properties
- Density: 1.564±0.06 g/cm3 (20 oC 760 Torr),
- Solubility: Almost insoluble (0.017 g/l) (25 o C),
- PSA: 12.89000
- LogP: 3.44480
4-Bromo-6-fluoro-2-methylquinoline Customs Data
- HS CODE:2933499090
- Customs Data:
China Customs Code:
2933499090Overview:
2933499090. Other compounds containing quinoline or isoquinoline ring system [but not further fused]. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
4-Bromo-6-fluoro-2-methylquinoline Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Fluorochem | 215899-1g |
4-Bromo-6-fluoro-2-methylquinoline |
1070879-47-8 | 95% | 1g |
£100.00 | 2022-03-01 | |
| Fluorochem | 215899-10g |
4-Bromo-6-fluoro-2-methylquinoline |
1070879-47-8 | 95% | 10g |
£525.00 | 2022-03-01 | |
| Alichem | A189007841-10g |
4-Bromo-6-fluoro-2-methylquinoline |
1070879-47-8 | 95% | 10g |
$402.99 | 2023-09-04 | |
| TRC | B692673-250mg |
4-Bromo-6-fluoro-2-methylquinoline |
1070879-47-8 | 250mg |
$ 87.00 | 2023-04-18 | ||
| TRC | B692673-500mg |
4-Bromo-6-fluoro-2-methylquinoline |
1070879-47-8 | 500mg |
$ 150.00 | 2023-04-18 | ||
| TRC | B692673-1g |
4-Bromo-6-fluoro-2-methylquinoline |
1070879-47-8 | 1g |
$ 215.00 | 2022-06-06 | ||
| Chemenu | CM145317-10g |
4-Bromo-6-fluoro-2-methylquinoline |
1070879-47-8 | 95% | 10g |
$373 | 2021-08-05 | |
| Apollo Scientific | PC404614-1g |
4-Bromo-6-fluoro-2-methylquinoline |
1070879-47-8 | 1g |
£167.00 | 2025-02-21 | ||
| Apollo Scientific | PC404614-5g |
4-Bromo-6-fluoro-2-methylquinoline |
1070879-47-8 | 5g |
£418.00 | 2025-02-21 | ||
| Ambeed | A772386-5g |
4-Bromo-6-fluoro-2-methylquinoline |
1070879-47-8 | 98% | 5g |
$510.0 | 2024-04-26 |
4-Bromo-6-fluoro-2-methylquinoline Related Literature
-
Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
-
Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511
-
Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
-
Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
-
Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
Additional information on 4-Bromo-6-fluoro-2-methylquinoline
4-Bromo-6-fluoro-2-methylquinoline (CAS No. 1070879-47-8): A Versatile Building Block in Medicinal Chemistry and Material Science
4-Bromo-6-fluoro-2-methylquinoline (CAS No. 1070879-47-8) is a highly valuable heterocyclic compound that has gained significant attention in pharmaceutical research and advanced material development. This halogenated quinoline derivative serves as a crucial intermediate in the synthesis of various biologically active molecules, particularly in the development of kinase inhibitors and antimicrobial agents. Its unique molecular structure, featuring both bromine and fluorine substituents on the quinoline core, makes it an exceptionally versatile building block for structure-activity relationship (SAR) studies.
The growing interest in 4-Bromo-6-fluoro-2-methylquinoline is reflected in recent scientific literature, with researchers exploring its potential in cancer drug discovery and central nervous system (CNS) therapeutics. The compound's electron-withdrawing properties, imparted by the halogen atoms, significantly influence its reactivity in cross-coupling reactions, making it particularly valuable for palladium-catalyzed transformations. These characteristics align perfectly with current trends in green chemistry and atom-efficient synthesis, addressing the pharmaceutical industry's need for more sustainable manufacturing processes.
From a structural perspective, 4-Bromo-6-fluoro-2-methylquinoline exhibits several noteworthy features. The methyl group at position 2 enhances the compound's stability while potentially influencing its binding affinity in biological systems. The bromine atom at position 4 serves as an excellent leaving group for various nucleophilic substitution reactions, while the fluorine at position 6 can significantly alter the molecule's electronic distribution and metabolic stability. These properties make this compound particularly valuable for medicinal chemistry optimization programs.
Recent applications of 4-Bromo-6-fluoro-2-methylquinoline have expanded beyond traditional pharmaceutical uses. Materials scientists are investigating its potential in organic electronic devices, particularly as a precursor for electron-transport materials in OLED technology. The compound's ability to form stable metal complexes has also sparked interest in catalysis research, where it may serve as a ligand for transition metal catalysts. These diverse applications demonstrate the compound's relevance in addressing current challenges in renewable energy technologies and sustainable chemical processes.
The synthesis and handling of 4-Bromo-6-fluoro-2-methylquinoline require specialized knowledge in heterocyclic chemistry. Modern synthetic approaches often employ microwave-assisted synthesis techniques to improve yield and reduce reaction times, reflecting the growing emphasis on process intensification in chemical manufacturing. Analytical characterization typically involves advanced techniques such as NMR spectroscopy and high-resolution mass spectrometry to ensure purity and confirm structural integrity, meeting the stringent requirements of pharmaceutical quality control.
Market demand for 4-Bromo-6-fluoro-2-methylquinoline has been steadily increasing, driven by its applications in drug discovery pipelines and material science innovations. Suppliers specializing in advanced pharmaceutical intermediates have reported growing interest from both academic research institutions and industrial R&D departments. The compound's commercial availability in various quantities, from milligram-scale for initial screening to kilogram quantities for process development, supports its widespread adoption across different stages of product development cycles.
From a regulatory perspective, 4-Bromo-6-fluoro-2-methylquinoline is generally classified as a research chemical rather than a controlled substance, making it accessible for legitimate scientific investigations. However, researchers must adhere to standard laboratory safety protocols when handling this compound, including proper personal protective equipment and adequate ventilation. The compound's stability under normal conditions and well-documented handling procedures contribute to its popularity as a synthetic building block in both academic and industrial settings.
Future research directions for 4-Bromo-6-fluoro-2-methylquinoline are likely to focus on expanding its utility in targeted drug delivery systems and bioorthogonal chemistry applications. The compound's structural features make it an attractive candidate for developing prodrug strategies and molecular probes for biological imaging. Additionally, its potential in metal-organic frameworks (MOFs) and coordination polymers represents an exciting frontier in materials science, where researchers seek to develop novel functional materials with tailored properties.
In conclusion, 4-Bromo-6-fluoro-2-methylquinoline (CAS No. 1070879-47-8) stands as a prime example of how carefully designed heterocyclic compounds can bridge multiple scientific disciplines. Its significance in medicinal chemistry, combined with emerging applications in advanced materials, ensures its continued relevance in addressing contemporary scientific challenges. As research into quinoline derivatives progresses, this particular compound will undoubtedly remain a valuable tool for scientists exploring the intersection of chemical structure and functional performance across various applications.
1070879-47-8 (4-Bromo-6-fluoro-2-methylquinoline) Related Products
- 31009-33-3(4-Bromo-6-fluoro-2-(trifluoromethyl)quinoline)
- 931414-04-9(5-BROMO-8-FLUORO-2-METHYLQUINOLINE)
- 80290-18-2(5-bromo-6-fluoro-2-methylquinoline)
- 50488-44-3(4-Bromo-2-methylquinoline)
- 1070879-49-0(4-Bromo-8-fluoro-2-methylquinoline)
- 1070879-54-7(4,7-dibromo-2-methylquinoline)
- 1070879-53-6(4,6-dibromo-2-methylquinoline)
- 1189106-86-2(4-Bromo-6,8-difluoro-2-methylquinoline)
- 1070879-48-9(4-Bromo-7-fluoro-2-methylquinoline)
- 958650-94-7(6-Bromo-8-fluoro-2-methylquinoline)